Sleeve Gastrectomy Failure-Revision to Laparoscopic One-Anastomosis Gastric Bypass or Roux-n-Y Gastric Bypass: a Multicenter Study.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
07 2021
Historique:
received: 15 12 2020
accepted: 04 03 2021
revised: 27 02 2021
pubmed: 26 3 2021
medline: 29 6 2021
entrez: 25 3 2021
Statut: ppublish

Résumé

Laparoscopic sleeve gastrectomy (LSG) is the most popular bariatric procedure performed worldwide. However, many patients undergo secondary surgery due to either weight-related and complication-related reasons or both. Conversional options vary with one-anastomosis gastric bypass (OAGB) and Roux-n-Y gastric bypass (RYGB) being the most common. The aim of the study was to assess the safety and efficacy of converting failed LSG to either OAGB or RYGB, and compare weight-related results and post-conversion complications. Retrospective review of hospital records of patients who underwent conversion from LSG to either RYGB or OAGB due to insufficient weight loss or weight regain in 7 bariatric centers between 2013 and 2019. Data retrieved included demographics, anthropometrics, comorbidities, indication for conversion, conversion type, complications, and weight loss. During the study period, 396 patients were included in the study. Eighty-four (21%) patients were lost to follow-up. RYGB and OAGB were performed in 119 and 144 patients, respectively. Mean age and body mass index (BMI) at revision were 44.2 years (range 19-72) and 40.6 ± 5.9 kg/m Conversion of LSG to OAGB, compared to RYGB, results in increased weight loss but a higher rate of GERD and potential nutritional deficiencies.

Identifiants

pubmed: 33765292
doi: 10.1007/s11695-021-05334-9
pii: 10.1007/s11695-021-05334-9
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2927-2934

Références

Welbourn R, Gagner M, Ottosson J, Naslund I, Kinsman R. The IFSO Global Registry. 2019. p. 1–100. Available from: https://www.ifso.com/pdf/5th-ifso-global-registry-report-september-2019.pdf . Accessed Sep 2019.
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. Obesity Surgery. 2019;29:782–95.
doi: 10.1007/s11695-018-3593-1
Altieri MS, Yang J, Nie L, Blackstone R, Spaniolas K, Pryor A. Rate of revisions or conversion after bariatric surgery over 10 years in the state of New York. Surg Obes Relat Dis. Elsevier Inc.; 2018;14:500–7. Available from: https://doi.org/10.1016/j.soard.2017.12.019 .
Parikh M, Ayoung-chee P, Romanos E, Lewis N, Pachter HL, Fielding G, et al. Comparison of rates of resolution of diabetes mellitus after gastric banding , gastric bypass , and biliopancreatic diversion. J Am Coll Surg 2019;631–635.
Clapp B, Wynn M, Martyn C, Foster C, O’Dell M, Tyroch A. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. Elsevier Inc.; 2018;14:741–7. Available from: https://doi.org/10.1016/j.soard.2018.02.027 .
Ponce J, DeMaria EJ, Nguyen NT, Hutter M, Sudan R, Morton JM. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis. Elsevier; 2016;12:1637–9. Available from: https://doi.org/10.1016/j.soard.2016.08.488 .
Lazzati A, Bechet S, Jouma S, et al. Revision surgery after sleeve gastrectomy: a nationwide study with 10 years of follow-up. Surg Obes Relat Dis. 2020;16:1497–504.
doi: 10.1016/j.soard.2020.05.021
Homan J, Betzel B, Aarts EO, Van Laarhoven KJHM, Janssen IMC, Berends FJ. Secondary surgery after sleeve gastrectomy: Roux-en-Y gastric bypass or biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. Elsevier; 2015;11:771–7. Available from: https://doi.org/10.1016/j.soard.2014.09.029 .
Langer FB, Bohdjalian A, Shakeri-Leidenmühler S, et al. Conversion from sleeve gastrectomy to roux-en-y gastric bypass-indications and outcome. Obes Surg. 2010;20:835–40.
doi: 10.1007/s11695-010-0125-z
Abdemur A, Han SM, Lo Menzo E, Szomstein S, Rosenthal R. Reasons and outcomes of conversion of laparoscopic sleeve gastrectomy to Roux-en-Y gastric bypass for nonresponders. Surg Obes Relat Dis. Elsevier; 2016;12:113–8. Available from: https://doi.org/10.1016/j.soard.2015.04.005 .
Moszkowicz D, Rau C, Guenzi M, Zinzindohoué F, Berger A, Chevallier JM. Laparoscopic omega-loop gastric bypass for the conversion of failed sleeve gastrectomy: early experience. J Visc Surg. Elsevier Masson SAS; 2013;150:373–8. Available from: https://doi.org/10.1016/j.jviscsurg.2013.08.010 .
Musella M, Bruni V, Greco F, Raffaelli M, Lucchese M, Susa A, et al. Conversion from laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) to one anastomosis gastric bypass (OAGB): preliminary data from a multicenter retrospective study. Surg Obes Relat Dis. Elsevier Inc.; 2019;15:1332–9. Available from: https://doi.org/10.1016/j.soard.2019.05.026 .
Jamal MH, Elabd R, AlMutairi R, et al. The safety and efficacy of one anastomosis gastric bypass as a revision for sleeve gastrectomy. Obes Surg. Obesity Surgery. 2020;30:2280–4.
doi: 10.1007/s11695-020-04484-6
Shimon O, Keidar A, Orgad R, et al. Long-term effectiveness of laparoscopic conversion of sleeve gastrectomy to a biliopancreatic diversion with a duodenal switch or a Roux-en-Y gastric bypass due to weight loss failure. Obes Surg. Obesity Surgery. 2018;28:1724–30.
doi: 10.1007/s11695-017-3086-7
Dijkhorst PJ, Boerboom AB, Janssen IMC, et al. Failed sleeve gastrectomy: single anastomosis duodenoileal bypass or Roux-en-Y gastric bypass? A multicenter cohort study. Obes Surg. Obesity Surgery. 2018;28:3834–42.
doi: 10.1007/s11695-018-3429-z
Kaplan U, Romano-Zelekha O, Goitein D, et al. Trends in bariatric surgery: a 5-year analysis of the Israel National Bariatric Surgery Registry. Obes Surg. Obesity Surgery. 2020;30:1761–7.
doi: 10.1007/s11695-020-04426-2
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242:20–8.
doi: 10.1097/01.sla.0000167762.46568.98
de la Cruz M, Büsing M, Dukovska R, et al. Short- to medium-term results of single-anastomosis duodeno-ileal bypass compared with one-anastomosis gastric bypass for weight recidivism after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2020;16:1060–6.
doi: 10.1016/j.soard.2020.04.014
Buchwald H. Revisional metabolic/bariatric surgery: a moral obligation. Obes Surg. 2015;25:547–9.
doi: 10.1007/s11695-014-1458-9
Park JY, Song D, Kim YJ. Causes and outcomes of revisional bariatric surgery: initial experience at a single center. Ann Surg Treat Res. 2014;86:295–301.
doi: 10.4174/astr.2014.86.6.295
Mohos E, Schmaldienst E, Prager M. Quality of life parameters, weight change and improvement of co-morbidities after laparoscopic roux y gastric bypass and laparoscopic gastric sleeve resection-comparative study. Obes Surg. 2011;21:288–94.
doi: 10.1007/s11695-010-0227-7
Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–56.
doi: 10.1016/S0016-5085(97)70025-8
El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17–26.
doi: 10.1016/j.cgh.2006.09.016
Hampel H, Abraham NS, El-Serag HB. Metaanalysis: obesity and the risk for gastroesophageal reflux disease and its complications. Yearb Med Inform. 2005;143:199–211.
Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.
doi: 10.1381/096089206778869933
Borbély Y, Kröll D, Nett PC, Moreno P, Tutuian R, Lenglinger J. Radiologic, endoscopic, and functional patterns in patients with symptomatic gastroesophageal reflux disease after Roux-en-Y gastric bypass. Surg Obes Relat Dis. Elsevier Inc.; 2018;14:764–8. Available from: https://doi.org/10.1016/j.soard.2018.02.028 .
Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.
doi: 10.1097/00000658-200010000-00007
Holmberg D, Santoni G, Xie S, et al. Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther. 2019;50:159–66.
doi: 10.1111/apt.15274
Landreneau JP, Strong AT, Rodriguez JH, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass. Obes Surg. Obesity Surgery. 2018;28:3843–50.
doi: 10.1007/s11695-018-3435-1
Yorke E, Sheppard C, Switzer NJ, Kim D, de Gara C, Karmali S, Kanji A, Birch D Revision of sleeve gastrectomy to Roux-en-Y gastric bypass: a Canadian experience. Am J Surg. Elsevier Ltd; 2017;213:970–4. Available from: https://doi.org/10.1016/j.amjsurg.2017.04.003 .
Georgiadou D, Sergentanis TN, Nixon A, Diamantis T, Tsigris C, Psaltopoulou T. Efficacy and safety of laparoscopic mini gastric bypass. A systematic review. Surg Obes Relat Dis. Elsevier; 2014;10:984–91. Available from: https://doi.org/10.1016/j.soard.2014.02.009 .
Runkel M, Runkel N. Esophago-gastric cancer after one anastomosis gastric bypass (OAGB). Chir. 2019;114:686–92.
Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15:398–404.
doi: 10.1381/0960892053576677
Enani G, Bilgic E, Lebedeva E, Delisle M, Vergis A, Hardy K. The incidence of iron deficiency anemia post-Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review. Surg Endosc. Springer US; 2020;34:3002–10. Available from: https://doi.org/10.1007/s00464-019-07092-3 .
Jamal W, Zagzoog MM, Sait SH, et al. Initial outcomes of one anastomosis gastric bypass at a single institution. Diabetes Metab Syndr Obes. 2019;12:35–41.
doi: 10.2147/DMSO.S180111
Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. Obesity Surgery. 2017;27:1153–67.
doi: 10.1007/s11695-016-2428-1

Auteurs

Shlomi Rayman (S)

Department of Surgery C, Chaim Sheba Medical Center, 2 Sheba Rd., 52610, Ramat Gan, Israel. shlomirayman@gmail.com.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. shlomirayman@gmail.com.

Dan Assaf (D)

Department of Surgery C, Chaim Sheba Medical Center, 2 Sheba Rd., 52610, Ramat Gan, Israel.

Carmil Azran (C)

Bariatric Center, Herzliya Medical Center, 7 Ramat Yam St, 4685107, Herzliya, Israel.

Gideon Sroka (G)

Department of General Surgery, Bnai-Zion Medical Center, Haifa, Israel.
Rappaport Faculty of Medicine, The Technion-Israel Institute of Technology, Haifa, Israel.

Ahmad Assalia (A)

Department of General Surgery, Rambam Health Care Campus and the Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

Nahum Beglaibter (N)

Department of Surgery, Hadassah-Hebrew University Medical Center, Mount Scopus, 91240, Jerusalem, Israel.

Ram Elazary (R)

Department of Surgery, Hadassah-Hebrew University Medical Center, Ein-Kerem Campus, Jerusalem, Israel.

Shai Meron Eldar (SM)

Department of General Surgery, The Tel-Aviv Sourasky Medical Center of Medicine, Tel Aviv University, Tel-Aviv-Yafo, Israel.

Orly Romano-Zelekha (O)

Israel Center for Disease Control, Ministry of Health, Tel Hashomer Campus, 56261, Ramat Gan, Israel.

David Goitein (D)

Department of Surgery C, Chaim Sheba Medical Center, 2 Sheba Rd., 52610, Ramat Gan, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH